| mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0006 |
| mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.005 |
| mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.005 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
| mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.006 |